Health · 20 views
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 20 Community interest
Brief read Under 1 min brief 40 words
Summary
The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published in the New England Journal of Medicine.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Vitamin A metabolite keeps immune cells active against recurrent brain tumorsContinue reading
- The stepping stones of memory are more fluid than once thoughtContinue reading
- Soft back belts ease everyday low back pain, 12-week trial suggestsContinue reading
- Whatever happened to the Taliban threat: 'We will flog the women'?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow